Pancreatitis Trial, Recruiting (NCT07536841)

Pancreatitis Trial, Recruiting NCT07536841 Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine Condition: Pancreatitis

Printed from Voxsanity (voxsanity.com.au) — NCT07536841 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be an adult aged 18 or older who is being assessed by doctors for a possible autoimmune condition affecting the pancreas
Your doctors must have access to the necessary test results, scans, blood work, and/or tissue samples needed to complete a specific scoring assessment used in this trial (called OC26 scoring)
If you are joining the trial going forward (rather than having your past records reviewed), you must be able to give your agreement to take part

Who may not be able to join:

You have already been diagnosed with a different condition that explains your pancreas-related findings, such as pancreatic cancer or another type of pancreatitis (inflammation of the pancreas caused by something other than an autoimmune condition)
Not enough test results or medical information is available to complete the scoring assessment used in this trial
You have previously had surgery on your pancreas that could affect how your test results and scans are interpreted

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Oleg Dovbenko, Odesa Regional Clinical Medical Center

Phone: +380682539685

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07536841

Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatitis

Trial contact: +380682539685

More information: https://clinicaltrials.gov/study/NCT07536841

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be an adult aged 18 or older who is being assessed by doctors for a possible autoimmune condition affecting the pancreas
Your doctors must have access to the necessary test results, scans, blood work, and/or tissue samples needed to complete a specific scoring assessment used in this trial (called OC26 scoring)
If you are joining the trial going forward (rather than having your past records reviewed), you must be able to give your agreement to take part

Who may not be able to join:

You have already been diagnosed with a different condition that explains your pancreas-related findings, such as pancreatic cancer or another type of pancreatitis (inflammation of the pancreas caused by something other than an autoimmune condition)
Not enough test results or medical information is available to complete the scoring assessment used in this trial
You have previously had surgery on your pancreas that could affect how your test results and scans are interpreted

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Military Medical Clinical Center of the Southern Region, Ukraine

Registry

ClinicalTrials.gov

Start date

1 May 2026

Est. completion

1 May 2026

Where this trial is recruiting

🇺🇦 Ukraine

Primary endpoints

Diagnostic accuracy of the Odesa Criteria 2026 (OC26) as a domain-based scoring system for autoimmune pancreatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov